Independent reference site — Not affiliated with the U.S. Food and Drug Administration. All data sourced from public FDA databases.
Updated weekly · FDA Drug Shortages Database

ADHD medication shortages

Every FDA-listed shortage of adhd medication. A shortage doesn't mean a drug is unsafe. It means supply is constrained. Drugs in this category include Adderall, Vyvanse, Ritalin, Concerta, Focalin.

Verified from FDA on Refreshes every weeklyFDA-Sourced
AllCurrently in shortageResolvedTo be discontinued
Sort by:Most recent updateLongest in shortageDrug A-Z

No shortages match the current filter. Try clearing the status filter, or browse all drug shortages.

What FDA considers a shortage

Currently in shortage: The manufacturer reports that supply does not meet projected demand. The drug is still being made and remains available, but pharmacies may run out or substitute alternative strengths. FDA verifies the report before adding the drug to the database.

Resolved: The manufacturer has restored supply or FDA has confirmed enough alternative supply exists to meet demand. The drug remains on the list for 6 months after resolution so users can confirm the shortage ended.

To be discontinued: The manufacturer has notified FDA that production will permanently stop. Existing supply will continue until depleted; no replenishment is planned. A different manufacturer may pick up production later.

Definitions sourced from the FDA Drug Shortages Database →

For information only. MedivaScan summarizes public FDA data and is not medical advice. Consult a healthcare professional before changing any medication. If you experience a serious reaction, contact your doctor or call 911.